VEGFC 抗体
(Vascular Endothelial Growth Factor C (VEGFC))
The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor D. [provided by RefSeq, Jul 2008].
recommended
recommended
VEGFC 适用: 人, 小鼠, 大鼠 WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
recommended
VEGFC 抗体 by 适用
Find VEGFC 抗体 for a variety of species such as anti-Human VEGFC, anti-Mouse VEGFC, anti-Rat VEGFC. The species listed below are among those available. Click on a link to go to the corresponding products.
VEGFC 抗体 by 抗体来源
Find VEGFC 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
VEGFC 抗体 by 克隆形成能力
Find available monoclonal or polyclonal VEGFC 抗体. Click on a link to go to the corresponding products.
Popular VEGFC 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Mouse
Application
WB, IHC, IP, ICC
Validations
- (6)
Cat. No.
ABIN7429439
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro)
Validations
- (3)
- (3)
Cat. No.
ABIN731723
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC, FACS
Validations
- (5)
Cat. No.
ABIN3029579
Quantity
0.4 mL
Datasheet
Datasheet
Reactivity
Human
Application
WB, FACS, IHC (p)
Validations
- (4)
Cat. No.
ABIN655891
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Rat
Application
WB, IHC, IP, ICC
Validations
- (2)
Cat. No.
ABIN7426628
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (2)
Cat. No.
ABIN7175372
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IHC (p)
Validations
- (2)
Cat. No.
ABIN1960114
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, ICC
Validations
- (3)
Cat. No.
ABIN1078652
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, FACS, IHC (p), EIA
Validations
- (3)
Cat. No.
ABIN955510
Quantity
0.4 mL
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB
Validations
- (1)
Cat. No.
ABIN4915116
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Rat
Application
WB, ELISA
Validations
- (1)
Cat. No.
ABIN1589911
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Dog
Application
WB, IHC, IP, ICC
Validations
- (1)
Cat. No.
ABIN7443968
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (1)
Cat. No.
ABIN563369
Quantity
50 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN948620
Quantity
50 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC, IHC (p)
Validations
- (1)
Cat. No.
ABIN1957196
Quantity
100 μg
Datasheet
Datasheet
Latest Publications for our VEGFC 抗体
: "KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D." in: eLife, Vol. 8, (2019) (PubMed).: "Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer." in: BMC cancer, Vol. 19, Issue 1, pp. 584, (2019) (PubMed).
: "Vascular restenosis in coronary artery bypass grafting might be associated with VEGF-C/VEGFR-3 signaling pathway." in: Heart and vessels, Vol. 33, Issue 9, pp. 1106-1120, (2018) (PubMed).
: "CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling." in: Biomedicine & pharmacotherapy, Vol. 106, pp. 1-7, (2018) (PubMed).
: "BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo." in: Molecular carcinogenesis, Vol. 56, Issue 3, pp. 1137-1149, (2017) (PubMed).
: "Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model." in: Anticancer research, Vol. 37, Issue 3, pp. 979-986, (2017) (PubMed).
: "Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab." in: British journal of cancer, Vol. 115, Issue 8, pp. 974-982, (2016) (PubMed).
: "Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer." in: Oncotarget, Vol. 7, Issue 14, pp. 18469-84, (2016) (PubMed).
: "Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome." in: Journal of cellular and molecular medicine, Vol. 20, Issue 4, pp. 613-22, (2016) (PubMed).
: "Concurrent Expression of VEGF-C and Neuropilin-2 Is Correlated with Poor Prognosis in Glioblastoma." in: The Tohoku journal of experimental medicine, Vol. 238, Issue 2, pp. 85-91, (2016) (PubMed).
Aliases for VEGFC 抗体
vascular endothelial growth factor c (vegfc) 抗体vascular endothelial growth factor C (VEGFC) 抗体
vascular endothelial growth factor C S homeolog (vegfc.S) 抗体
vascular endothelial growth factor C (Vegfc) 抗体
AW228853 抗体
Flt4-L 抗体
vegf-c 抗体
VEGF-C 抗体
VEGFC 抗体
VRP 抗体
xvegf-c 抗体
您还需要查找其他产品吗？
- VEGFB 抗体
- VEGF121 抗体
- VEGF 抗体
- VDAC3 抗体
- VDAC2 抗体
- VDAC1 抗体
- VCX3A 抗体
- VCX 抗体
- Vcpip1 抗体
- Vcan 抗体
- VCAM1 抗体
- VBP1 抗体
- VAX2 抗体
- VAV3 抗体
- VAV2 抗体
- VAV1 抗体
- VAT1 抗体
- VASP 抗体
- Vasopressin 抗体
- Vasohibin 2 抗体
- VEGFD 抗体
- VEGFR2/CD309 抗体
- Ventral Anterior Homeobox 1 抗体
- VENTX 抗体
- Very Low Density Lipoprotein 抗体
- Vesicle Transport Protein SFT2B 抗体
- Vesicle-Associated Membrane Protein 1 (Synaptobrevin 1) 抗体
- Vestigial 抗体
- Vestigial Like 2 抗体
- VEZF1 抗体
- VEZT 抗体
- VGF 抗体
- VGLL1 抗体
- VGLL3 抗体
- VGLL4 抗体
- VHL 抗体
- VHLL 抗体
- VILL 抗体
- Villin 1 抗体
- Vimentin 抗体
You are here:
